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Background. In industrial large scale bio-reactions micro-organisms are generally exposed to a variety of environmental
stresses, which might be detrimental for growth and productivity. Reactive oxygen species (ROS) play a key role among the
common stress factors–directly-through incomplete reduction of O2 during respiration, or indirectly-caused by other stressing
factors. Vitamin C or L-ascorbic acid acts as a scavenger of ROS, thereby potentially protecting cells from harmful oxidative
products. While most eukaryotes synthesize ascorbic acid, yeast cells produce erythro-ascorbic acid instead. The actual
importance of this antioxidant substance for the yeast is still a subject of scientific debate. Methodology/Principal Findings.
We set out to enable Saccharomyces cerevisiae cells to produce ascorbic acid intracellularly to protect the cells from
detrimental effects of environmental stresses. We report for the first time the biosynthesis of L-ascorbic acid from D-glucose by
metabolically engineered yeast cells. The amount of L-ascorbic acid produced leads to an improved robustness of the
recombinant cells when they are subjected to stress conditions as often met during industrial fermentations. Not only
resistance against oxidative agents as H2O2 is increased, but also the tolerance to low pH and weak organic acids at low pH is
increased. Conclusions/Significance. This platform provides a new tool whose commercial applications may have
a substantial impact on bio-industrial production of Vitamin C. Furthermore, we propose S. cerevisiae cells endogenously
producing vitamin C as a cellular model to study the genesis/protection of ROS as well as genotoxicity.
Citation: Branduardi P, Fossati T, Sauer M, Pagani R, Mattanovich D, et al (2007) Biosynthesis of Vitamin C by Yeast Leads to Increased Stress
Resistance. PLoS ONE 2(10): e1092. doi:10.1371/journal.pone.0001092
INTRODUCTION
Micro-organisms maintain optimal growth (and productivity) within
areasonablybroadrangeofphysiologicalconditions,duetoavariety
of responses that have evolved to cope with many types of
environmental insult. Cellular defense mechanisms are able to avoid
molecular damages in a wide range of environmental conditions.
However, this balance can be disturbed severely in industrial scale
bio-reactions where micro-organisms are generally exposed to
a variety of environmental stresses [1,2]. In addition to unfavorable
exterior conditions the heavy metabolic burden imposed by an
efficient production process is another cause for cellular stress.
Regardless of their origin, stresses on micro-organisms can have
various effects, including lower metabolic activity, growth rate, or
productivity or decreased viability. In an industrial process, wherein
the micro-organism is used as a means for production, the
mentioned effects lead finally to a lower concentration of the
product, lower productivity, or a decreased yield. Stress is therefore
an undesirable phenomenon, and techniques for minimizing it-
particularly in industrial processes-are highly desirable.
Reactive oxygen species (ROS) play a key role among the
common stress factors [3–5].
This might be directly–by the generation of ROS due to the
incomplete reduction of O2 during respiration-or indirectly–when
ROS generation is caused by other stressing factors–metabolical or
environmental. Most eukaryotic organisms produce L-ascorbic
acid (L-AA or vitamin C), a powerful, water-soluble antioxidant as
scavenger of ROS [6–8] to prevent or at least alleviate deleterious
effects caused by ROS. However, yeast cells naturally lack the
ability to produce L-AA. Instead, erythro-ascorbic acid, a struc-
turally related compound with chemical properties very similar to
those of L-AA, is the molecule occurring to a low extent in yeast
cells [9]. Its role for stress resistance has been shown, but to which
extend it is important is still a question for scientific debate [9–11].
Here, we report for the first time the biosynthesis of L-AA by
metabolically engineered S. cerevisiae cells starting from D-glucose. We
showthattheendogenous biosynthesis of ascorbic acid in yeast and its
scavenger role against ROS leads to an improved cell viability of the
recombinant cells during growth under various stress conditions.
RESULTS
Construction of recombinant S. cerevisiae strains
able to convert D-glucose into L-ascorbic acid
Animals and plants employ two different metabolic pathways to
synthesize L-ascorbic acid [12,13]. The plant pathway (shown in
fig 1) was chosen for L-AA production in yeast cells for two
reasons: First of all, GDP-mannose, a key intermediate in this
pathway, is naturally produced in yeasts for cell wall construction
[14]. Secondly, the last two steps for biosynthesis of L-AA in plants
show similarity to the pathway of production of erythro-ascorbic
acid in yeasts. Useful enzymes are therefore already present within
the cells. It has been demonstrated that yeast strains incubated in
the presence of L-galactose are able to produce L-ascorbic acid
[15]. This capacity can be enhanced by overexpression of the
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LGDH gene. In this case, L-AA is even accumulated extracellularly
[16] upon incubation of the cells with L-galactose.
Only the three enzymatic activities converting GDP-D-mannose
into L-galactose are thereforemissing inyeastcells.Toclose thisgap,
the following genes were cloned and expressed under the control of
the TPI promoter (Table 1): AtME (A. thaliana mannose epimerase),
converting GDP-D-mannose into GDP-L-galactose and AtMIP/
VTC4 (A. thaliana myo-inositol phosphatase/L-galactose-1-P-phos-
phatase), converting L-galactose-1-P into L-galactose. Since the
enzyme responsible for the conversion of GDP-L-galactose into L-
galactose was only recently identified [17], alternative pyropho-
sphorylases converting substrates similar to GDP-L-galactose were
sought for in the database. L-fucose guanylyl-transferase (FGT) from
Rattus norvegicus [18] appeared suitable and was finally expressed.
Additionally, AtLGDH (A. thaliana L-galactose dehydrogenase) which
allows the conversion of L-galactose into L-galactono-1,4-lactone
and ScALO (S. cerevisiae D-arabinono-1,4-lactone oxidase), converting
L-galactono-1,4-lactone into L-AA were co-expressed, to make sure
that no bottleneck is created in the end of the pathway.
The resulting integrative and/or centromeric expression
plasmids (all five or, alternatively, all except the one harboring
the RnFGT gene) were used to transform the S. cerevisiae strains
GRF18U and BY4742 (see Table 1 and 2 for a complete list of
plasmids and strains). Two different yeast strains were examined in
parallel to elucidate the effect of a different genetic background.
Independent clones of the obtained recombinant strains, together
with their respective control strains, were grown in shake flasks
with D-glucose as the sole carbon source. Their ability to convert
D-glucose into L-ascorbic acid was measured by a chemical assay
[19]. Figure 2 clearly shows for both genetic backgrounds that the
recombinant strains do produce low, but significant and re-
producible amounts of vitamin C. Wild type cells as well as
recombinant cells transformed with ScALO and AtLGDH were
analyzed as negative control. For the cells expressing ScALO and
AtLGDH we had previously proven a high accumulation of vitamin
C, when the cells are incubated with L-galactose [16]. However,
the basal level of endogenous antioxidants is similar for both the
wild-type (first column) and these recombinant cells (second
column) incubated with glucose. Adding two more of the genes
from the L-AA metabolic pathway (AtME and AtMIP) the vitamin
is already detectable (third column, for both graphs, strain
BY4742[ScALO AtLGDH AtME AtMIP] and GRF18U[ScALO
AtLGDH AtME AtMIP]). This result indicates the presence of
endogenous pyrophosphorylase activities converting GDP-L-
galactose into L-galactose-1-P. The level of L-ascorbic acid
becomes even higher when the RnFGT gene is added (fourth
column), proving the suitability of this enzyme for our purpose.
While the trend of ascorbic acid production for both strains is
similar, the absolute values are significantly different, being almost
one order of magnitude lower in the BY background (Fig. 2, left
panel). Analogous, the contribution of the RnFGT gene is more
effective in the GRF background (Fig. 2, right panel). On the other
hand, while such difference could be related to the different
genetic background of the two hosts, the basal level of antioxidants
appears to be within the same order of magnitude in both yeast
Figure 1. Ascorbic acid biosynthetic pathway. Schematic representation of the pathway of L-AA production from D-glucose in plants. The following
enzymes are involved: A, hexokinase (2.7.1.1), B, glucose-6-phosphate isomerase (5.3.1.9), C, mannose-6-phosphate isomerase (5.3.1.8), D,
phosphomannomutase (5.4.2.8), E, mannose-1-phosphate guanylyltransferase (2.7.7.22), F, GDP-mannose-3,5-epimerase (5.1.3.18), G, GDP-L-galactose
phosphorylase (E.C.C not assigned), H, L-Galactose 1-phosphate phosphatase (3.1.3.25), I, L-galactose dehydrogenase, J, L-galactono-1,4-lactone
dehydrogenase (1.3.2.3).
doi:10.1371/journal.pone.0001092.g001
Table 1. List of expression plasmids constructed and used in this study*
..................................................................................................................................................
Expression vector Promoter Expressed protein Plasmid status Selection Transformed strain
p012 MIP Sc TPI At Myo-Inositol Phosphatase/L-Galactose-1P Phosphatase INT Sc URA3 BY4742
p012bT ME-MIP Zb TPI/ScTPI At GDP-Mannose-39,59-Epimerase/ At Myo-Inositol Phosphatase/L-
Galactose-1P Phosphatase
INT Sc URA3 GRF18U
p022 LGDH Sc TPI At L-Galactose Dehydrogenase INT Sc HIS3 BY4742/GRF18U
p042 ALO Sc TPI Sc D-Arabinono-1,4-lactone oxydase INT Sc LEU2 BY4742/GRF18U
p062 ME Sc TPI At GDP-Mannose-39,59-Epimerase INT Sc LYS2 BY4742/GRF18U
pZ3 ME Sc TPI At GDP-Mannose-39,59-Epimerase CEN Kan
R GRF18U
pZ5 FGT Sc TPI Rn GDP-L-Fucose Pyrophosphorylase CEN Nat
R BY4742/GRF18U
Abbreviations: Sc: Saccharomyces cerevisiae;A t :Arabidopsis thaliana; Rn: Rattus norvegicus; Zb: Zygosaccharomyces bailii;
TPI: Triose Phosphate Isomerase
URA3, HIS3, LEU2, LYS2: gene markers conferring growth to auxotrophic yeast strains in the absence of uracil, histidine, leucine and lysine, respectively.
Nat
R: cassette conferring resistance to nourseotricine.
Kan
R: cassette conferring resistance to Geneticin.
CEN and INT: centromeric and integrative plasmids, respectively.
*a complete description of plasmids construction is given in Materials and Methods
doi:10.1371/journal.pone.0001092.t001
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PLoS ONE | www.plosone.org 2 October 2007 | Issue 10 | e1092backgrounds. In no case vitamin C was detectable in the culture
broth (data not shown).
Effects of endogenous L-AA production on strain
robustness: recombinant yeasts behavior under
oxidative stress
To test if the endogenous production of vitamin C could have
beneficial biological effects, wild type BY4742, GRF18U and the
correspondingrecombinantL-AAproducingstrainswerechallenged
by growing the cells under different stress conditions. Since vitamin
C acts principally as an antioxidant, the first condition used to test
the robustness of the engineered strains was oxidative stress. Yeast
cells were inoculated at an initial optical density (660 nm) of 0.1 in
the presence of different concentrations of H2O2 (ranging from 2 to
3.5 mM), and their growth was measured as optical density at
specific intervals of time over about 80 hours, Figure 3. Cells were
also inoculated in the same medium without H2O2, as a control. As
expected, in the absence of H2O2 both wild type and recombinant
strains grew well (Fig. 3a and 3b). When H2O2 was added to the
medium, the growth of both GRF18U and BY4742 wild type strains
was negatively affected proportionally to the hydrogen peroxide
concentration. Low concentrations (2 mM) lead to a slight delay of
growth (data not shown), while the highest H2O2 concentration
Table 2. List of yeast strains constructed and used in this study
..................................................................................................................................................
Strain Genotype Source
GRF18U MATa his3-11 his3-15 leu2-3 leu2-112 ura3 [NRRL Y30320] [25]
GRF18Uc MATa his3-11 his3-15 leu2-3 leu2-112 ura3 [pYX012; pYX022; pYX042] This study
GRF18U ALO LGDH MATa his3-11 his3-15 leu2-3 leu2-112 ura3 [p022AtLGDH; p042ScALO] [9]
GRF18U ALO LGDH ME MIP MATa his3-11 his3-15 leu2-3 leu2-112 ura3 [p022AtLGDH; p042ScALO; pZ3AtME;
p012AtMIP]
This study
GRF18U ALO LGDH bTME MIP MATa his3-11 his3-15 leu2-3 leu2-112 ura3 [p022AtLGDH; p042ScALO; p012bTAtME AtMIP] This study
GRF18U ALO LGDH bTME MIP FGT MATa his3-11 his3-15 leu2-3 leu2-112 ura3 [p022AtLGDH; p042ScALO; p012bTAtME AtMIP; pZ5RnFGT] This study
BY4742 MATa; his3D1; leu2D0; lys2D0; ura3D0 (EuroScarf AN. Y10000) [26]
BY4742c MATa; his3D1; leu2D0; lys2D0; ura3D0 [pYX012; pYX022; pYX042; pYX062] This study
BY4742 ALO LGDH MATa; his3D1; leu2D0; lys2D0; ura3D0 [pYX012; p022AtLGDH; p042 ScALO; pYX062] This study
BY4742 ALO LGDH ME MATa; his3D1; leu2D0; lys2D0; ura3D0 [pYX012; p022AtLGDH; p042ScALO; p062AtME] This study
BY4742 ALO LGDH ME MIP MATa; his3D1; leu2D0; lys2D0; ura3D0 [p012AtMIP; p022AtLGDH; p042ScALO; p062AtME] This study
BY4742 ALO LGDH ME MIP FGT MATa; his3D1; leu2D0; lys2D0; ura3D0 [p012AtMIP; p022AtLGDH; p042ScALO; p062AtME; pZ5RnFGT] This study
doi:10.1371/journal.pone.0001092.t002
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Figure 2. Conversion of D-Glucose into L-ascorbic acid (milligrams/liter/OD) by transformed S. cerevisiae GRF18U and BY4742 cells. All strains
were grown on mineral medium (2% w/v glucose, 0.67% w/v YNB), starting with an initial OD660 of 0.05 for 18 h, when samples were taken and the
concentration of L-ascorbic acid inside the cells was determined (GRF18U and BY4742 correspond to the parental strains transformed with the empty
plasmids harboring in the productive strains the genes of the L-AA pathway). The control cells, as well as the cells expressing ScALO1 and AtLGDH can
not accumulate L-ascorbic acid starting from D-glucose, therefore measured values correspond to the endogenous erythro-ascorbic acid. The
standard deviation bars correspond to the data obtained from independent clones, and from independent growth and antioxidant determinations.
Please note the different scale of the ordinate axes in the two graphs.
doi:10.1371/journal.pone.0001092.g002
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PLoS ONE | www.plosone.org 3 October 2007 | Issue 10 | e1092(3.5 mM) lead to an almost complete growth inhibition (Fig. 3c and
3d). A similar behavior has been observed for yeast cells transformed
with the ScALO1a n dAtLGDH genes (data not shown). Significantly,
under the same limiting conditions, all recombinant strains
producing L-AA were able to resume growth about 35 hours after
inoculation, showing a strong robustness and an increased tolerance
to oxidative stress (Fig. 3c and 3d). Moreover, it becomes obvious
that this aspect of strain robustness is directly correlated with the
amount of L-AA produced (see Fig. 2); in fact, the strains engineered
with all five genes necessary to complete the biosynthetic L-AA
pathway exhibited even stronger tolerance (Fig. 3c and 3d, triangles)
than the corresponding strains, lacking the FGT activity (Fig. 3c and
3d, squares). This phenomenon can be observed for both yeast
genetic backgrounds, even if with a slight difference in timing,
probably due to a different basal resistance of the two genetic
backgrounds (phenomenon not further investigated). The BY
background strain, in fact, seems to be more resistant, despite the
generally lower ascorbic acid levels measured (see Fig. 2).
Similar results were obtained for cells growing in the presence of
2.5 and 3 mM H2O2. In these cases growth was resumed 20 and
25 hours after inoculation, respectively (data not shown), hence
earlier and concentration dependent.
Effects of endogenous L-AA production on strain
robustness: recombinant strain behavior under
acidic stress
To test if the improved strain robustness could be extended to
other environmental constraints, wild type and engineered strains
were subjected to acidic stress caused by inorganic or organic
acids. These are typical environmental conditions occurring
during either lab-batch and industrial fermentations.
To this purpose, we analyzed wild type and ascorbic acid
producing strains grown in minimal medium brought to pH 2.2
with HCl addition (acidic stress induced by inorganic acid), or with
lactic acid (45 g/l) at pH 3 (this value was chosen in order to have
Figure 3. Growth curves of wild type and L-ascorbic acid producing yeasts under oxidative stress. Kinetics of growth of wild type and engineered
strains GRF18U (left panels) and BY4742 (right panels) as inoculated in minimal glucose media without H2O2 (3A and 3B) or in presence of H2O2
3.5 mM (3C and 3D). N GRF18U wild type; & GRF18U[ScALO AtLGDH AtME AtMIP]; m GRF18U[ScALO AtLGDH AtME AtMIP RnFGT]; # BY4742 wild type;
% BY4742[ScALO AtLGDH AtME AtMIP]; n BY4742[ScALO AtLGDH AtME AtMIP RnFGT].
doi:10.1371/journal.pone.0001092.g003
Cloning the Vitamin C Pathway
PLoS ONE | www.plosone.org 4 October 2007 | Issue 10 | e1092the organic acid almost completely in the undissociated form, since
its pKa is 3.78). From the data presented in Figure 4, it is evident
that also under these stress conditions the producing strains exhibit
a strong robustness and increased tolerance when compared to
control strain. At pH 2.2 (Fig. 4a) the growth rate of the wild type
strains are significantly delayed in respect to the growth rate of the
engineered strains.
Furthermore, the addition of 45 g/l of lactic acid to the medium
has dramatic effects on the wild type strains, which are completely
inhibited in growth, and also on the [ScALO AtLGDH AtME AtMIP]
expressing cells which are severely compromised, while the
recombinant strains expressing all genes for L-AA production are
still able to grow (Fig. 4b). Interestingly, the effect of L-AA produced
intracellularly is much more profound than the effect of vitamin C
added to the culture broth. Fig. 4c shows the growth curve of wild
type control cells in presence of lactic acid (40 g/l) at low pH. The
addition of ascorbic acid relieves the growth inhibition evidently, but
even with 60 mg/l the effect is not as profound as with the low
amountsproducedintracellularly.Thegrowthisresumedmuchlater
even while less lactic acid was added to the culture.
Correlation of endogenous L-AA concentration,
strain robustness and viability
Having proven the positive effects on growth under stress
conditions as described above, we wanted to deeper investigate
the correlation between ascorbic acid endogenously produced by
engineered yeast cells, enhanced tolerance to oxidative damage
and cell robustness. The wild type and the recombinant GRF18U
and BY strains were grown in minimal glucose medium with
addition of 3.0 mM H2O2, following the same experimental
protocol described in Figure 3. At the time in which all strains start
to recover from the imposed stress (each with a different kinetic:
approximately after 2–3 duplications from the preinoculum–as
example see Figure 3), samples were taken. Each sample was
stained with Dihydrorhodamine123 for the detection of ROS [20],
and PI (propidium iodide) to detect severely damaged and/or dead
cells [21]. Samples were analyzed with a flow cytometer. The
resulting dot plots are compared in Figure 5. On the dot plots
(DHR123 vs. PI) each individual cell is represented by a single dot
and it is quite easy to recognize at least four distinct yeast
subpopulations. A first healthy subpopulation (named A in Fig. 5a,
used as a schematic representation for the benefit of the following
ones), having only the background signal (autofluorescence) for
both fluorochromes (low DHR and low PI signal); a second
subpopulation (named B in Fig. 5a) of still viable but ROS
accumulating cells (low PI, high rhodamine signal); a third
subpopulation (named C in Fig. 5a) made of damaged cells
displaying high ROS and high PI signals and finally a fourth
subpopulation (named D in Fig 5a) of dead cells, presumably
originated from subpopulation C by loosing all DHR signal. The
data reported in the upper (GRF18U background) panels of
Figure 4. Growth curves of wild type and L-ascorbic acid producing yeasts under acidic stress. Growth curves of wild type and engineered
GRF18U and BY strains (upper and lower panel, respectively) inoculated in minimal glucose media at low inorganic pH (panel A) or at low pH plus
organic acid (lactic acid, 45g/l, panel B) or at low pH plus organic acid with L-AA added exogenously (panel C). Panels 4A and 4B: N GRF18U wild type;
& GRF18U[ScALO AtLGDH AtME AtMIP]; m GRF18U[ScALO AtLGDH AtME AtMIP RnFGT]; # BY4742 wild type; % BY4742 [ScALO AtLGDH AtME AtMIP]; n
BY4742 [ScALO AtLGDH AtME AtMIP RnFGT]; Panel 4C: N GRF18U wild type; # BY4742 wild type; 2 GRF18U or BY4742 wild type added with 30mg/l
ascorbic acid; * GRF18U or BY4742 wild type added with 60 mg/l ascorbic acid.
doi:10.1371/journal.pone.0001092.g004
Cloning the Vitamin C Pathway
PLoS ONE | www.plosone.org 5 October 2007 | Issue 10 | e1092Figure 5 (b, c, d) clearly show that in the wild type strain the
oxidative stress induced by H2O2 strongly influences the
intracellular ROS content and affects cell vitality. In fact, as
clearly shown by Fig. 5b, a considerable portion of the analyzed
cells (28%) shows high intracellular levels of ROS, and the fraction
of dead cells (33%) exceeds that of viable cells (28%). By contrast,
in the recombinant strains producing L-AA (Fig. 5c), we registered
a clear reduction of ROS formation, (15% of the total population),
together with a decrease of cell mortality (30%) and a consequent
improved cell viability (44%). This trend is maximized in the strain
expressing the RnFGT gene (Fig. 5d), where the majority of the
cells (89.5%) is still viable and healthy, while ROS formation
(1.1%) and cell mortality (8.7%) are almost negligible. As already
observed for the growth curves in limiting conditions, also in this
experiment there is a direct and positive correlation between the
levels of vitamin C produced (see Fig. 2) and cell viability.
A corresponding result has been observed for the BY yeast
background (lower panels). While the general trend for both
strains is similar, in this case, accordingly to the higher robustness
observed for this genetic background (compare the behaviors of
the GRF18U and BY cells in Figure 3 and 4 ) a lower
accumulation of ROS has been detected.
Taken together these data allow a more deeper analysis of the
data shown in Figure 3 where increasing H2O2 concentration lead
to longer delays of growth. These longer delays are clearly due to
decreasing fractions of viable cells at the time of inolucum.
The same cells analysed by flow cytometry can also be analysed
with a fluorescence microscope for ROS accumulation. In the wild
type strain, cells with a strong and granular rhodamine staining are
quite frequent and well represented, while in the producing strain
almost no signal for ROS is detectable (data not shown).
All the described data demonstrate that the endogenous
production of the antioxidant L-AA protects cells from oxidative
damage, scavenging the intracellular production of ROS and/or
increasing cell viability.
DISCUSSION
We report for the first time the biosynthesis of vitamin C by
recombinant S. cerevisiae cells starting from D-glucose. Accumulation
of ascorbic acid was proven to be successful in two different strains
(Figure 2). Furthermore, we proved that the intracellular accumu-
lation of L-AA leads to an improved robustness of the recombinant
yeasts during growth under different stress conditions. The
recombinant yeasts that are functionally transformed to produce
L-ascorbic acid generate lower levels of ROS (Fig. 5) and exhibit
improved growth and a higher viability under conditions of organic
(Fig.4b)and inorganic(Fig.4a) acid stressesaswell as oxidativestress
(Fig. 3c and d). These are physiological conditions often encountered
during industrial large scale fermentations. For each yeast
background, the degree of robustness seems to be directly related
to the amount of intracellularly produced vitamin C (Fig. 2, 3 and 4).
In accordance with our data it has been shown before that the
addition of ascorbic acid to the growth medium has beneficial effects
for heterologous protein production in yeasts [22].
Furthermore, the respective yeast strains are a major step for the
development of a cellfactory for theproduction of vitaminC itself, one
of the most important specialty chemicals manufactured in the
world. This aim has been long sought for, but never reached up to
now [23–25].Inthisrespect, itis noteworthythat we have previously
shown that (i) yeast cells do have one or more transporters which
allow the accumulation of intracellularly produced ascorbic acid in
the culture medium (i.e., thus greatly facilitating the purification
procedures) and (ii) that S. cerevisiae cells are quite tolerant to high
concentrations of ascorbic acid (at least 40–50 g/L) [16]. Conse-
quently, the industrial production of ascorbic acid by a one-step
fermentation from D-glucose appears closer then ever.
Figure 5. Flow cytometric analysis of wild type and vitamin C producing yeasts under oxidative stress. Panel 5A: schematic representation of the
different subpopulations that can be observed in the following panels, where wild type (5B) and recombinant strains (5C and 5D) grown in minimal
glucose medium added with H2O2 3.0 mM were analyzed after DHR123 and PI staining (rodamine signal is reported in the abscissa and PI signal on
the ordinate axes). Upper panels: GRF18U background. Lower panels: BY background. (B): wild type. (C): [ScALO AtLGDH AtME AtMIP] transformed
cells. (D): [ScALO AtLGDH AtME AtMIP RnFGT] transformed cells
doi:10.1371/journal.pone.0001092.g005
Cloning the Vitamin C Pathway
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role of ROS. It is well known that the production of ROS is
common for many types of cancer cells and that vitamin C has
a positive effect in reducing the incidence of stomach, lung and
colorectal cancer [26,27]. On the other hand vitamin C can under
certain circumstances even increase the generation of ROS and
could have detrimental effects at least under certain circumstances
[28–30]. Hopefully, S. cerevisiae cells endogenously producing
vitamin C could represent a well suited cellular model to study the
genesis/protection of ROS and genotoxicity in higher eukaryotic
organisms.
MATERIALS AND METHODS
Yeast strains, transformation, media and cultivation
The S. cerevisiae parental strains used in this study were GRF18U
[31] (MATa; ura3; leu2-3,112; his3-11,15; cir
+), and BY4742
(MATa; ura3D0; his3D1; leu2D0; lys2D0; cir
+), EuroScarf Accession
No. Y10000-http://www.rz.uni-frankfurt.de/FB/fb16/mikro/
euroscarf). Yeast transformations were performed according to
the LiAc/PEG/ss-DNA protocol [32] and both strains were
transformed with one or more of the constructs described below,
in parallel with the corresponding empty plasmid(s). The presence
of the heterologous genes was confirmed by PCR analysis. For
each set of transformation at least three independent clones were
initially tested, showing no meaningful differences among them.
The resulting S. cerevisiae strains constructed in this study are listed
in Table 2, with their respective genotypes. In GRF18U the
plasmid integration is locus specific (the auxotrophies were
generated by multiple point mutations of the target genes), while
integration is randomly directed in cells of the BY background.
Yeast cultures were grown in minimal synthetic medium (0.67%
w/v YNB Biolife without amino acids) with 2% w/v of D-glucose
as carbon source. When required, supplements such as leucine,
uracil, lysine and histidine were added to a final concentration of
50 mg/l, while the antibiotic nourseotricine sulphate (cloNAT,
WERNER BioAgents, Germany) was added to a final concentra-
tion of 100 mg/l.
In the case of growth under oxidative or acidic stress, the desired
stress condition was imposed by adding different concentrations of
H2O2 (specifically 2, 2.5, 3 and 3.5 mM) or of lactic acid (45 g/l)
directly to the medium or by lowering the medium pH to 2.2 with
HCl 6N. In the case of lactic acid addition, the pH value was
adjusted to 3 with NaOH 4N. Yeast cells were inoculated at an
initial optical density of 0.1 (always 660 nm where not differently
specified) and then optical density was measured at specific
intervals of time over at least 55 hours from the inoculum. Each
experiment was repeated at least three times.
All strains were grown in shake flasks at 30uC and 160 rpm and
the ratio of flask volume/medium was of 5/1.
Gene amplification and expression plasmid
construction
All genes for the reconstruction of the L-AA pathway in yeast were
PCR amplified on a GeneAmp PCR System 9700 (PE Appl.
Biosystems, Inc.) using Pwo DNA Polymerase (Roche Diagnostics)
and following the manufacturer’s instructions. Template DNA for
AtLGDH, AtME, and AtMIP was a cDNA library from A. thaliana
(ATCC 77500) [33]; template DNA for ScALO1 consisted of 50 ng
of genomic DNA from S. cerevisiae GRF18U, extracted with
a standard method (according to [34], slightly modified) RnFGT
was PCR amplified from a kidney cDNA library (Origene, CR-
1003). The following primer pairs were used: for ALO1: ALO1for
TTT CAC CAT ATG TCT ACT ATC C and ALO1rev AAG
GAT CCT AGT CGG ACA ACT C; for LGDH,: LGDHfor ATG
ACG AAA ATA GAG CTT CGA GC and LGDHrev TTA GTT
CTG ATG GAT TCC ACT TGG; for ME: MEfor GCG CCA
TGG GAA CTA CCA ATG GAA CA and MErev GCG CTC
GAG TCA CTC TTT TCC ATC A; for MIP: Mipfor ATC CAT
GGC GGA CAA TGA TTC TC and MIPrev AAT CAT GCC
CCT GTA AGC CGC; for FGT FGTfor TAG GAC ATG GAG
ACT CTC CGG GAA and FGTrev CTC AAT TAA GAT TTC
TCT AAA TCA GAT TGT TTT TTA TTT GA.
The PCR fragments were sub-cloned into the pSTBlue-1 vector
using the Perfectly Blunt Cloning kit (Novagen) and checked by
sequence analysis. The obtained sequences were the same as those
reported in Genebank except for MIP in which two silent point
substitutions (A271T and T685G) were detected. Finally, the
coding sequences were EcoRI cut and sub-cloned into S. cerevisiae
expression vectors of the YX series (R&D Systems, Inc.) or
derivates (pYX012bT and pYX062, generated for this study, see
below) and into the centromeric expression vectors pZ3, pZ3bT
[35] and pZ5 (this study, see below). In detail, ALO1 was sub-
cloned into pYX042 (integrative, LEU2 auxotrophic marker,
ScTPI promoter); LGDH was sub-cloned into pYX022 (integrative,
HIS3 auxotrophic marker, ScTPI promoter), and ME and MIP
into pYX062 (integrative, LYS2 auxotrophic marker, PCR
amplified with oligonucleotides LYS2for TGC CAG CGG AAT
TCC ACT TGC and LYS2rev AAT CTT TGT GAA GCT
TCG CAA GTA TTC ATT from S. cerevisiae genome and
substituted to the URA3 auxotrophic marker in the plasmid
pYX012 DraIII/NotI cut and blunt ended, ScTPI promoter) and
pYX012 (integrative, URA3 auxotrophic marker, ScTPI promoter)
respectively. ME EcoRI cut and blunt ended was also sub-cloned
into pZ3bT (centromeric, G418
R dominant marker, ZbTPI
promoter) XbaI cut, blunt ended: the expression cassette bT
promoter-AtME-polyA terminator was then PCR amplified with
oligonucleotides btTPIfor ATC GTA TTG CTT CAA TTC
TTC TTC TTT TGTA and polyAKpnrev GGG GTA CCC
CAG CTG GAG CTA GAC AAA GAC which has a recognition
sequence for KpnI at the 59 site; the cassette was then subcloned
into pSTBlue-1 vector, and, after sequencing, KpnI excised and
sub-cloned into pYX012-MIP KpnI cut, resulting in the pYX012
bTME-MIP expression vector. This construct allowed the in-
tegration of two heterologous genes into the yeast genome at the
same time by the use of single marker of selection. Finally, RnFGT
EcoRI cut was sub-cloned into pZ5. This is a centromeric vector
derived from pBR1 (pYX022 in which the ARS-CEN fragment
from Ycplac33 has been inserted [35]). pBR1 was cut KpnI and
blunt ended, and the nourseotricine cassette (Nat
R) PvuII/SacI cut
and blunt ended from pAG25 [36], has been inserted. All the
restriction and modification enzymes used were from New
England Biolabs (Hitchin, Herts, UK) or from Roche Diagnostics
(Mannheim, Germany). Standard procedures [37] were employed
for all cloning purposes.
All plasmids generated and utilized for the present study are
described in Table 1.
Determination of L-ascorbic acid
For intracellular L-ascorbic acid determinations yeast cells were
inoculated at an initial optical density of 0.05 in minimal medium
and grown for about 18 hours in order to reach a mid-exponential
phase of growth. Cells were then harvested by centrifugation at
4000 rpm for 5 min at 4uC, washed once with ice-cold distilled
water and then resuspended in about three times volume of ice-
cold 10% (w/v) trichloroacetic acid, vortexed vigorously, and kept
in ice for 20 minutes. The supernatant was then cleared from cell
debris by centrifugation. Ascorbic acid was determined spectro-
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et Clarke [16,19]. We previously confirmed the identity of ascorbic
acid by HPLC using yeast cells functionally transformed to
produce ascorbic acid from L-galactose [16].
Flow cytometric analyses
Reactive oxygen species (ROS) were detected by Dihydrorhoda-
mine 123 as described in [20]. Cells were incubated with
Dihydrorhodamine 123 (DHR 123, Sigma Chemical Co., St.
Louis, MO, USA) for 2 h, washed twice with PBS buffer and
subsequently resuspended in propidium iodide solution 0.46 mM
for the identification of dead or severely compromised cells.
Samples were then analyzed using a Cell Lab Quanta
TM SC flow
cytometer (Beckman Coulter, Fullerton, CA, USA) equipped with
a diode laser (excitation wavelength 488 nm, laser power 22 mW).
The fluorescence emission was measured through a 525–550 nm
band pass filter (FL1 parameter) for DHR signal and through
a 670 nm long pass filter (FL3 parameter) for PI signal. The
sample flow rate during analysis did not exceed 600–700 cells/s. A
total of 20,000 cells was measured for each sample. Data analysis
was performed afterwards with WinMDI 2.8 software, build#13
01-19-2000 (Purdue University, Cytometry Laboratories [http://
facs.scripps.edu/software.html]).
Fluorescence microscopy
Samples of the same yeast cultures treated and FACS analyzed for
ROS content were also directly analysed using a Nikon Eclipse 90i
fluorescence microscope (excitation, 488 nm) using standard FITC
filters. Images were taken using the software Metamorph 2.2.
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